MabCure (MBCI) Financial Statements
MabCure Financial Overview
MabCure's market cap is currently $32.18K. The company's EPS TTM is ―; its P/E ratio is -0.00; MabCure has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 11 | Dec 10 | Dec 09 | Dec 08 | Dec 07 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ― | ― | ― | ― | ― |
| Gross Profit | $ 500.00K | $ 0.00 | $ 0.00 | $ 0.00 | ― |
| Operating Income | $ -709.75K | $ -1.02M | $ -1.36M | $ -535.96K | $ -106.27K |
| EBITDA | $ -12.05M | $ -975.87K | $ -1.31M | $ -525.48K | $ -106.27K |
| Net Income | $ -12.26M | $ -1.23M | $ -1.37M | $ -530.51K | $ -106.27K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ― | ― | ― | ― | ― |
| Total Assets | $ 4.81M | $ 16.21M | $ 16.45M | $ 19.49M | $ 0.00 |
| Total Debt | $ 261.16K | $ 185.84K | $ 93.14K | $ 181.34K | $ 0.00 |
| Net Debt | $ 114.73K | $ 182.43K | $ -121.34K | $ -630.10K | $ 0.00 |
| Total Liabilities | $ 935.15K | $ 482.51K | $ 833.04K | $ 286.48K | $ 49.27K |
| Stockholders' Equity | ― | ― | ― | ― | ― |
| Cash Flow | |||||
| Free Cash Flow | $ -62.65K | $ -705.78K | $ -1.08M | $ -625.30K | $ -90.27K |
| Operating Cash Flow | ― | ― | ― | ― | ― |
| Investing Cash Flow | ― | ― | ― | ― | ― |
| Financing Cash Flow | ― | ― | ― | ― | ― |
Currency in USD